Literature DB >> 3129319

A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis.

A M Dlugi1, S Rufo, J F D'Amico, M M Seibel.   

Abstract

Twelve patients receiving Buserelin and seven patients receiving danazol for treatment of endometriosis were studied to assess the effect of medication on plasma lipoproteins. Danazol significantly lowered plasma HDL-C levels at 6 months of treatment. Total plasma cholesterol was elevated at 6 months of therapy in the Buserelin group. No effect by either drug on plasma triglycerides was seen.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3129319     DOI： 10.1016/s0015-0282(16)59906-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  4 in total

Review 1.  Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.

Authors:  R N Brogden; M M Buckley; A Ward
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

2.  [Treatment of endometriosis].

Authors:  L Kiesel; K Bertges; T R von Holst; B Runnebaum
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

3.  The impact of D-Trp6 LH-RH on plasma lipid levels.

Authors:  G A Goldman; A Schoenfeld; J Ovadia; B Fisch
Journal:  J Assist Reprod Genet       Date:  1996-03       Impact factor: 3.412

Review 4.  Clinical uses of gonadotropin-releasing hormone analogues.

Authors:  R F Casper
Journal:  CMAJ       Date:  1991-01-15       Impact factor: 8.262
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.